| INDPIndaptus Therapeutics, Inc. |
n/d |
n/d |
2025 |
| INACIndigo Acquisition Corp. |
n/d |
n/d |
2025 |
| INDVIndivior Pharmaceuticals, Inc. |
US$ 1,2 bi |
16,9% |
2025 |
| PIFMFIndofood Sukses Makmur, Tbk |
n/d |
n/d |
n/d |
| INDOIndonesia Energy Corp Ltd |
US$ 2 mi |
-253,2% |
2025 |
| IDEXFIndustria de Diseno Textil Inditex SA / ADR |
n/d |
n/d |
n/d |
| ILPTIndustrial Logistics Properties Trust |
n/d |
n/d |
2025 |
| IEAGInfinite Eagle Acquisition Corp. |
n/d |
n/d |
n/d |
| IFRXInflaRx N.V. |
€ 29,3 mil |
-155.582,1% |
2025 |
| IPCXInflection Point Acquisition Corp. III |
US$ 100 mi |
0,5% |
2025 |
| IPEXInflection Point Acquisition Corp. V |
n/d |
n/d |
2025 |
| IPFXInflection Point Acquisition Corp. VI |
n/d |
n/d |
n/d |
| INFQInfleqtion, Inc. |
n/d |
n/d |
2025 |
| IFBDInfobird Co., Ltd |
US$ 8,7 mi |
-615,9% |
2025 |
| IIIInformation Services Group Inc. |
US$ 244,7 mi |
3,8% |
2025 |
| INFYInfosys Ltd |
US$ 19,3 bi |
16,4% |
2025 |
| INFUInfuSystem Holdings, Inc |
US$ 143,4 mi |
4,6% |
2025 |
| IRIngersoll Rand Inc. |
US$ 7,7 bi |
7,6% |
2025 |
| NGVTIngevity Corp |
US$ 1,2 bi |
-14,3% |
2025 |
| INGMIngram Micro Holding Corp |
US$ 52,6 bi |
0,6% |
2025 |
| INGRIngredion Inc |
US$ 7,2 bi |
10,1% |
2025 |
| IKTInhibikase Therapeutics, Inc. |
n/d |
n/d |
2025 |
| INTIInhibitor Therapeutics, Inc. |
n/d |
n/d |
2025 |
| INBXInhibrx Biosciences, Inc. |
US$ 1,3 mi |
-10.773,5% |
2025 |
| INREInland Real Estate Income Trust, Inc. |
US$ 153,6 mi |
-7,2% |
2025 |
| INMBInmune Bio, Inc. |
US$ 50 mil |
-91.866,0% |
2025 |
| IPHAInnate Pharma SA |
€ 9 mi |
-546,1% |
2025 |
| INNVInnovAge Holding Corp. |
US$ 989,7 mi |
-0,3% |
2026 |
| INNIInnovaro, Inc. |
US$ 530,8 mil |
-1.882,3% |
2012 |
| IBGInnovation Beverage Group Ltd |
US$ 2,8 mi |
-223,4% |
2025 |
| IDIAInnovative Digital Investors Acquisition Corp. |
n/d |
n/d |
n/d |
| LUCYInnovative Eyewear Inc |
US$ 2,7 mi |
-285,2% |
2025 |
| IPSIInnovative Payment Solutions, Inc. |
n/d |
n/d |
2025 |
| IVBXFInnovent Biologics Inc |
n/d |
n/d |
n/d |
| INVXInnovex International, Inc. |
US$ 978,3 mi |
8,5% |
2025 |
| INVAInnoviva, Inc. |
US$ 411,3 mi |
65,9% |
2025 |
| INVZInnoviz Technologies Ltd. |
US$ 55,1 mi |
-123,1% |
2025 |
| INVInnventure, Inc. |
US$ 2,1 mi |
-14.266,4% |
2025 |
| INGNInogen Inc |
US$ 348,7 mi |
-6,5% |
2025 |
| NOTVQInotiv, Inc. |
US$ 513 mi |
-13,4% |
2025 |
| DYORInsight Digital Partners II |
n/d |
n/d |
n/d |
| IMDXInsight Molecular Diagnostics Inc. |
US$ 4,1 mi |
-1.238,5% |
2025 |
| INSPInspire Medical Systems, Inc. |
US$ 912 mi |
15,9% |
2025 |
| NSPRInspireMD, Inc. |
US$ 9 mi |
-543,3% |
2025 |
| INSEInspired Entertainment, Inc. |
US$ 304,1 mi |
-5,6% |
2025 |
| IBPInstalled Building Products, Inc. |
US$ 3 bi |
8,9% |
2025 |
| TILInstil Bio, Inc. |
n/d |
n/d |
2025 |
| INTAIntapp, Inc. |
US$ 577,8 mi |
-7,1% |
2026 |
| ICGIntchains Group Ltd |
US$ 31,6 mi |
-21,5% |
2025 |
| ITGRInteger Holdings Corp |
US$ 1,9 bi |
5,5% |
2025 |